IP Library Granted Patent US 8,404,825
Granted Patent B2
US 8,404,825 · App. 12/947,708 · Granted Mar 26, 2013

Method for producing monoterpene and monoterpinoid compounds and use thereof

Inventors: Claus Tittiger (Reno, NV); Rubi Figueroa-Teran (Reno, NV); Gary J. Blomquist (Sparks, NV)
Assignee: Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,404,825
App. No.
12/947,708
Granted
Mar 26, 2013
Kind
B2
Abstract

In various embodiments, the present disclosure provides a method and enzyme for forming various compounds, such as monoterpenes and monoterpenoid compounds. In a specific example, the present disclosure provides a method for producing one or more of (−)-ipsdienol, (−)-ipsenol, ipsenone, and ipsdienone. The present disclosure also provides methods of using compounds formed from the disclosed method and enzyme.

Claims (16)

1. An isolated, synthetic, or recombinant polynucleotide sequence at least 95% homologous to the sequence of SEQ ID NO:1 which encodes a polypeptide having oxidation reduction or oxidoreductase activity.

2. The polynucleotide sequence of claim 1 , wherein the sequence is at least 99% homologous to the sequence of SEQ ID NO:1.

3. A fragment of the polynucleotide sequence of claim 1 , that encodes a polypeptide having oxidation reduction or oxidoreductase activity.

4. A method of producing a polypeptide having oxidation or reduction activity comprising:

introducing the polynucleotide of claim 1 into an isolated host cell;

culturing the host cell;

expressing from the host cell a polypeptide, wherein the polypeptide has oxidation or reduction activity; and

isolating the polypeptide.

5. A method of generating a variant of a polypeptide having oxidation or reduction activity comprising:

providing a template nucleic acid comprising a sequence encoding a polypeptide at least 95% amino acid sequence similarity to the polypeptide encoded by the sequence of SEQ ID NO:1;

modifying, deleting or adding one or more nucleotides in the template sequence, or a combination thereof, to generate a variant of the template nucleic acid, wherein the variant encodes a polypeptide having oxidation or reduction activity; and

determining whether the polypeptide encoded by the variant catalytically oxidizes or reduces a substrate.

6. The method of claim 5 , wherein the substrate comprises one or more of ipsenone, ipsenol, ipsdienone, and ipsdienol.

7. A transgenic host cell produced by inserting the polynucleotide of claim 1 into the host cell.

8. An isolated transgenic host cell produced by inserting a polynucleotide of claim 1 .

9. The isolated, synthetic, or recombinant polynucleotide sequence of claim 1 , wherein the polynucleotide sequence is the sequence of SEQ ID NO:1.

Assignments (3)
CONFIRMATORY LICENSE Recorded May 25, 2012
From: UNIVERSITY OF NEVADA RENO
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028275/0447 →
CONFIRMATORY LICENSE Recorded May 24, 2012
From: UNIVERSITY OF NEVADA RENO
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028274/0822 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2011
From: TITTIGER, CLAUS; BLOMQUIST, GARY; FIGUEROA-TERAN, RUBI
To: BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO
Reel/Frame 026372/0417 →
Continuity (2)
Provisional Application 61115623 · Nov 18, 2008
Related Publication 20120107265A1 · May 3, 2012